Published: Jul 09, 2021, 04:50 IST | Updated: Jul 09, 2021, 04:50 IST
Pfizer and BioNTech have announced that they would seek the FDA's approval for the third dose of their COVID-19 vaccine to boost its efficacy, as the Delta variant is increasingly becoming a global dominant.